GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Total Receivables

PCL (XKRX:241820) Total Receivables : ₩4,959 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PCL Total Receivables?

PCL's Total Receivables for the quarter that ended in Mar. 2024 was ₩4,959 Mil.


PCL Total Receivables Historical Data

The historical data trend for PCL's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCL Total Receivables Chart

PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 210.31 692.73 1,752.74 7,469.83 10,170.47

PCL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,437.96 1,109.79 3,156.84 10,170.47 4,959.21

PCL Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


PCL Total Receivables Related Terms

Thank you for viewing the detailed overview of PCL's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PCL (XKRX:241820) Business Description

Traded in Other Exchanges
N/A
Address
Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL (XKRX:241820) Headlines

No Headlines